Resultados de la búsqueda 21-30 of 14496 for breast cancer
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Eliminating Breast Cancer Surgery in Exceptional Responders with Neoadjuvant Systemic Therapy. Rochester, Minn. The goal of this clinical research study is to ...
Living with cáncer de mama? Connect with others like you for support and answers to your questions in the Breast Cancer support group on Mayo Clinic Connect, a ...
The goal of this research is to identify risk profiles of women (with particular emphasis on Hispanic women) for breast cancer based on family history, ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...
The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?